Document
Effects of Agave salmiana Otto ex Salm-Dick high-fructose syrup on non-diabetic and streptozotocin-diabetic rats
Diabetes has become a serious public health problem worldwide. In Mexico, it has become the leading cause of death. Fructose in diabetic diet remains controversial because it%27s potential adverse effects on serum lipids. Forty eight rats were randomly assigned to one of the eight treatments resulting from a complete 2 X 4 factorial arrangement of treatments. In non-diabetic (ND) and streptozotocin-diabetic (D) rats we evaluate HFAS (high-fructose agave syrup) intake on plasma concentrations of diabetes related compounds. HFAS (0.0, 0.5, 2.0 and 5.0 g/kg body weight) was fed daily for six weeks to ND and D rats. Plasma glucose, cholesterol, triglycerides, blood glycosylated hemoglobin (HbA 1c), urine albumin and creatinine and liver steatosis were evaluated. Intake decreased linearly in D rats and showed a quadratic trend in ND rats. The HFAS did not affect weight gain. Triglycerides in D rats increased linearly as HFAS doses increased. There were quadratic opposite trends of glucose and HbA 1c, as HFAS doses increased; 0.5 g dose had the major impact on these variables. Streptozotocin-diabetic rats fed 2 and 5 g HFAS/kg body weight had lower liver steatosis than those non-supplemented with HFAS. Dietary HFAS did not show negative effects on food intake, weight gain and hiperglucemia in both ND and D rats. Apparently HFAS had a protective effect on steatosis in D rats. © 2009 Academic Journals.
Diabetes has become a serious public health problem worldwide. In Mexico, it has become the leading cause of death. Fructose in diabetic diet remains controversial because it's potential adverse effects on serum lipids. Forty eight rats were randomly assigned to one of the eight treatments resulting from a complete 2 X 4 factorial arrangement of treatments. In non-diabetic (ND) and streptozotocin-diabetic (D) rats we evaluate HFAS (high-fructose agave syrup) intake on plasma concentrations of diabetes related compounds. HFAS (0.0, 0.5, 2.0 and 5.0 g/kg body weight) was fed daily for six weeks to ND and D rats. Plasma glucose, cholesterol, triglycerides, blood glycosylated hemoglobin (HbA 1c), urine albumin and creatinine and liver steatosis were evaluated. Intake decreased linearly in D rats and showed a quadratic trend in ND rats. The HFAS did not affect weight gain. Triglycerides in D rats increased linearly as HFAS doses increased. There were quadratic opposite trends of glucose and HbA 1c, as HFAS doses increased; 0.5 g dose had the major impact on these variables. Streptozotocin-diabetic rats fed 2 and 5 g HFAS/kg body weight had lower liver steatosis than those non-supplemented with HFAS. Dietary HFAS did not show negative effects on food intake, weight gain and hiperglucemia in both ND and D rats. Apparently HFAS had a protective effect on steatosis in D rats. © 2009 Academic Journals.
Diabetes; Glucose; High-fructose agave syrup; Liver steatosis; Sweetener; Triglycerides albumin; fructose; glycosylated hemoglobin; sweetening agent; agave; Agave salmiana; animal experiment; animal model; animal tissue; article; cholesterol blood level; controlled study; correlation analysis; creatinine urine level; diabetic diet; dietary intake; experimental model; fatty liver; food intake; glucose blood level; hemoglobin determination; high fructose agave syrup; hyperglycemia; liver protection; male; nonhuman; protein urine level; rat; streptozocin diabetes; sugar intake; syrup; triacylglycerol blood level; weight gain; Agave; Agave salmiana; Rattus
Generically Dependent Continuant
RDF description of Effects of Agave salmiana Otto ex Salm-Dick high-fructose syrup on non-diabetic and streptozotocin-diabetic rats - http://orbis.uaslp.mx/vivo/individual/scopus2279
Article
Information Content Entity